Nanotherapeutic Modulation of Human Neural Cells and Glioblastoma in Organoids and Monocultures

Inflammatory processes in the brain are orchestrated by microglia and astrocytes in response to activators such as pathogen-associated molecular patterns, danger-associated molecular patterns and some nanostructures. Microglia are the primary immune responders in the brain and initiate responses amp...

Full description

Bibliographic Details
Main Authors: Issan Zhang, Paula Lépine, Chanshuai Han, María Lacalle-Aurioles, Carol X.-Q. Chen, Rainer Haag, Thomas M. Durcan, Dusica Maysinger
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/9/11/2434
_version_ 1827702596513562624
author Issan Zhang
Paula Lépine
Chanshuai Han
María Lacalle-Aurioles
Carol X.-Q. Chen
Rainer Haag
Thomas M. Durcan
Dusica Maysinger
author_facet Issan Zhang
Paula Lépine
Chanshuai Han
María Lacalle-Aurioles
Carol X.-Q. Chen
Rainer Haag
Thomas M. Durcan
Dusica Maysinger
author_sort Issan Zhang
collection DOAJ
description Inflammatory processes in the brain are orchestrated by microglia and astrocytes in response to activators such as pathogen-associated molecular patterns, danger-associated molecular patterns and some nanostructures. Microglia are the primary immune responders in the brain and initiate responses amplified by astrocytes through intercellular signaling. Intercellular communication between neural cells can be studied in cerebral organoids, co-cultures or in vivo. We used human cerebral organoids and glioblastoma co-cultures to study glia modulation by dendritic polyglycerol sulfate (dPGS). dPGS is an extensively studied nanostructure with inherent anti-inflammatory properties. Under inflammatory conditions, lipocalin-2 levels in astrocytes are markedly increased and indirectly enhanced by soluble factors released from hyperactive microglia. dPGS is an effective anti-inflammatory modulator of these markers. Our results show that dPGS can enter neural cells in cerebral organoids and glial cells in monocultures in a time-dependent manner. dPGS markedly reduces lipocalin-2 abundance in the neural cells. Glioblastoma tumoroids of astrocytic origin respond to activated microglia with enhanced invasiveness, whereas conditioned media from dPGS-treated microglia reduce tumoroid invasiveness. Considering that many nanostructures have only been tested in cancer cells and rodent models, experiments in human 3D cerebral organoids and co-cultures are complementary in vitro models to evaluate nanotherapeutics in the pre-clinical setting. Thoroughly characterized organoids and standardized procedures for their preparation are prerequisites to gain information of translational value in nanomedicine. This study provides data for a well-characterized dendrimer (dPGS) that modulates the activation state of human microglia implicated in brain tumor invasiveness.
first_indexed 2024-03-10T15:00:31Z
format Article
id doaj.art-171cdaa0a0e84917b308b3e1aaf31426
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T15:00:31Z
publishDate 2020-11-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-171cdaa0a0e84917b308b3e1aaf314262023-11-20T20:10:04ZengMDPI AGCells2073-44092020-11-01911243410.3390/cells9112434Nanotherapeutic Modulation of Human Neural Cells and Glioblastoma in Organoids and MonoculturesIssan Zhang0Paula Lépine1Chanshuai Han2María Lacalle-Aurioles3Carol X.-Q. Chen4Rainer Haag5Thomas M. Durcan6Dusica Maysinger7Department of Pharmacology and Therapeutics, McGill University, 3655 Promenade Sir-William-Osler, Montreal, QC H3G 1Y6, CanadaThe Neuro’s Early Drug Discovery Unit (EDDU), McGill University, 3801 University Street, Montreal, QC H3A 2B4, CanadaThe Neuro’s Early Drug Discovery Unit (EDDU), McGill University, 3801 University Street, Montreal, QC H3A 2B4, CanadaThe Neuro’s Early Drug Discovery Unit (EDDU), McGill University, 3801 University Street, Montreal, QC H3A 2B4, CanadaThe Neuro’s Early Drug Discovery Unit (EDDU), McGill University, 3801 University Street, Montreal, QC H3A 2B4, CanadaInstitute of Chemistry and Biochemistry, Freie Universität Berlin, Takustraße 3, 14195 Berlin, GermanyThe Neuro’s Early Drug Discovery Unit (EDDU), McGill University, 3801 University Street, Montreal, QC H3A 2B4, CanadaDepartment of Pharmacology and Therapeutics, McGill University, 3655 Promenade Sir-William-Osler, Montreal, QC H3G 1Y6, CanadaInflammatory processes in the brain are orchestrated by microglia and astrocytes in response to activators such as pathogen-associated molecular patterns, danger-associated molecular patterns and some nanostructures. Microglia are the primary immune responders in the brain and initiate responses amplified by astrocytes through intercellular signaling. Intercellular communication between neural cells can be studied in cerebral organoids, co-cultures or in vivo. We used human cerebral organoids and glioblastoma co-cultures to study glia modulation by dendritic polyglycerol sulfate (dPGS). dPGS is an extensively studied nanostructure with inherent anti-inflammatory properties. Under inflammatory conditions, lipocalin-2 levels in astrocytes are markedly increased and indirectly enhanced by soluble factors released from hyperactive microglia. dPGS is an effective anti-inflammatory modulator of these markers. Our results show that dPGS can enter neural cells in cerebral organoids and glial cells in monocultures in a time-dependent manner. dPGS markedly reduces lipocalin-2 abundance in the neural cells. Glioblastoma tumoroids of astrocytic origin respond to activated microglia with enhanced invasiveness, whereas conditioned media from dPGS-treated microglia reduce tumoroid invasiveness. Considering that many nanostructures have only been tested in cancer cells and rodent models, experiments in human 3D cerebral organoids and co-cultures are complementary in vitro models to evaluate nanotherapeutics in the pre-clinical setting. Thoroughly characterized organoids and standardized procedures for their preparation are prerequisites to gain information of translational value in nanomedicine. This study provides data for a well-characterized dendrimer (dPGS) that modulates the activation state of human microglia implicated in brain tumor invasiveness.https://www.mdpi.com/2073-4409/9/11/2434cerebral organoidsnanomedicinesastrocytesmicrogliaglioblastomalipocalin-2
spellingShingle Issan Zhang
Paula Lépine
Chanshuai Han
María Lacalle-Aurioles
Carol X.-Q. Chen
Rainer Haag
Thomas M. Durcan
Dusica Maysinger
Nanotherapeutic Modulation of Human Neural Cells and Glioblastoma in Organoids and Monocultures
Cells
cerebral organoids
nanomedicines
astrocytes
microglia
glioblastoma
lipocalin-2
title Nanotherapeutic Modulation of Human Neural Cells and Glioblastoma in Organoids and Monocultures
title_full Nanotherapeutic Modulation of Human Neural Cells and Glioblastoma in Organoids and Monocultures
title_fullStr Nanotherapeutic Modulation of Human Neural Cells and Glioblastoma in Organoids and Monocultures
title_full_unstemmed Nanotherapeutic Modulation of Human Neural Cells and Glioblastoma in Organoids and Monocultures
title_short Nanotherapeutic Modulation of Human Neural Cells and Glioblastoma in Organoids and Monocultures
title_sort nanotherapeutic modulation of human neural cells and glioblastoma in organoids and monocultures
topic cerebral organoids
nanomedicines
astrocytes
microglia
glioblastoma
lipocalin-2
url https://www.mdpi.com/2073-4409/9/11/2434
work_keys_str_mv AT issanzhang nanotherapeuticmodulationofhumanneuralcellsandglioblastomainorganoidsandmonocultures
AT paulalepine nanotherapeuticmodulationofhumanneuralcellsandglioblastomainorganoidsandmonocultures
AT chanshuaihan nanotherapeuticmodulationofhumanneuralcellsandglioblastomainorganoidsandmonocultures
AT marialacalleaurioles nanotherapeuticmodulationofhumanneuralcellsandglioblastomainorganoidsandmonocultures
AT carolxqchen nanotherapeuticmodulationofhumanneuralcellsandglioblastomainorganoidsandmonocultures
AT rainerhaag nanotherapeuticmodulationofhumanneuralcellsandglioblastomainorganoidsandmonocultures
AT thomasmdurcan nanotherapeuticmodulationofhumanneuralcellsandglioblastomainorganoidsandmonocultures
AT dusicamaysinger nanotherapeuticmodulationofhumanneuralcellsandglioblastomainorganoidsandmonocultures